7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB
- PMID: 16510574
- DOI: 10.1158/0008-5472.CAN-05-3056
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB
Abstract
The aberrant expression of the nuclear factor-kappaB (NF-kappaB) c-Rel subunit that occurs in many human breast cancers can play a causal role in tumorigenesis as judged by findings with a mouse mammary tumor virus (MMTV)-c-rel transgenic mouse model, in which 31.6% of mice developed one or more mammary tumors after a long latency. Interestingly, none of the cell lines established from the mammary tumors grew in soft agar. To begin to test the hypothesis that a prototypic carcinogen insult can promote a more invasive, mesenchymal phenotype, a cell line established from a MMTV-c-rel mammary tumor rel-3983 was treated in culture with the polycyclic aromatic hydrocarbon 7,12-dimethylbenz(a)anthracene (DMBA; rel-3983D cells) or DMSO vehicle (rel-3983V cells). Rel-3983D cells displayed an increased rate of proliferation, displayed growth to a higher cell density, and acquired the ability to grow in soft agar and in Matrigel compared with the parental rel-3983 or vehicle-treated rel-3983V cells. Consistent with a more mesenchymal phenotype, rel-3983D cells showed loss of E-cadherin expression as judged by immunofluorescence microscopy. Compared with control cells, rel-3983D displayed increased NF-kappaB binding and higher levels of the NF-kappaB transactivating subunits c-Rel, RelA, and RelB, which seemed functional as judged by induction of c-Myc and vimentin, products of two NF-kappaB target genes. Ectopic expression of a super repressor mutant of IkappaB-alpha reduced rel-3983D cell growth and invasive morphology in Matrigel, confirming the role of NF-kappaB in epithelial to mesenchymal transition (EMT). Thus, DMBA treatment of c-Rel-transformed mammary tumor cells in culture is shown here for the first time to result in EMT via activation of NF-kappaB. The aberrant c-Rel expression present in most human breast cancers suggests that this mechanism may play an important role in carcinogenesis.
Similar articles
-
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.Mol Cell Biol. 2005 Nov;25(22):10136-47. doi: 10.1128/MCB.25.22.10136-10147.2005. Mol Cell Biol. 2005. PMID: 16260626 Free PMC article.
-
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.Cancer Res. 2005 Dec 15;65(24):11375-83. doi: 10.1158/0008-5472.CAN-05-1602. Cancer Res. 2005. PMID: 16357145
-
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.J Clin Invest. 1997 Dec 15;100(12):2952-60. doi: 10.1172/JCI119848. J Clin Invest. 1997. PMID: 9399940 Free PMC article.
-
NF-kappaB and epithelial to mesenchymal transition of cancer.J Cell Biochem. 2008 Jun 1;104(3):733-44. doi: 10.1002/jcb.21695. J Cell Biochem. 2008. PMID: 18253935 Review.
-
Aberrant rel/nfkb genes and activity in human cancer.Oncogene. 1999 Nov 22;18(49):6938-47. doi: 10.1038/sj.onc.1203221. Oncogene. 1999. PMID: 10602468 Review.
Cited by
-
TAp63 is a transcriptional target of NF-kappaB.J Cell Biochem. 2010 Mar 1;109(4):702-10. doi: 10.1002/jcb.22449. J Cell Biochem. 2010. PMID: 20052674 Free PMC article.
-
Vimentin and PSF act in concert to regulate IbeA+ E. coli K1 induced activation and nuclear translocation of NF-κB in human brain endothelial cells.PLoS One. 2012;7(4):e35862. doi: 10.1371/journal.pone.0035862. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536447 Free PMC article.
-
Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.Crit Rev Oncog. 2017;22(1-2):49-61. doi: 10.1615/CritRevOncog.2017020473. Crit Rev Oncog. 2017. PMID: 29604936 Free PMC article. Review.
-
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.Nat Cell Biol. 2007 Apr;9(4):470-8. doi: 10.1038/ncb1559. Epub 2007 Mar 18. Nat Cell Biol. 2007. PMID: 17369819 Free PMC article.
-
Epithelial-mesenchymal transition: a new target in anticancer drug discovery.Nat Rev Drug Discov. 2016 May;15(5):311-25. doi: 10.1038/nrd.2015.13. Epub 2016 Jan 29. Nat Rev Drug Discov. 2016. PMID: 26822829
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources